Home › Galena Biopharma Inc (GALE) Price Target Lowered to $6.00 at Roth Capital
 

Keywords :   


Galena Biopharma Inc (GALE) Price Target Lowered to $6.00 at Roth Capital

2016-01-01 17:14:30| Biotech - Topix.net

The brokerage presently has a "buy" rating on the biotechnology company's stock. Roth Capital's price objective indicates a potential upside of 308.16% from the company's current price.

Tags: price capital target gale

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »